James C Mullen Editas Medicine, Inc. (EDIT) insider trading activity
James C Mullen is CEO of Editas Medicine, Inc.. Currently has a direct ownership of 75,898 shares of EDIT, which is worth approximately $272,473. The most recent transaction as insider was on Jan 03, 2022, when has been sold 18,252 shares (Common Stock) at a price of $26.95 per share, resulting in proceeds of $491,891. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
75.9K
0%
3M change
0%
12M change
Total Value Held
$272,473
JAMES C MULLEN Transaction History
Also insider at
JCM
James C Mullen
CEO
Waltham, MA